Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

For the 18th year running, Apple leads the list of the World's Most Admired Companies. The list, in its 27th year, is created in partnership between Fortune and Korn Ferry (NYSE:KFY).

Every year, 21.5 million people are forcibly displaced by floods, droughts, wildfires, and storms. This number ...

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) shares, maintaining an Outperform rating and a $105.00 price target. This confirmation followed the U.S. Food and Drug ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of ...

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...

When Novo Nordisk unveiled kidney outcomes data for its star GLP-1 medicine Ozempic last May, the company’s executive medical ...